Latest cervical cancer Stories

(Ivanhoe Newswire) – The HPV (human papillomavirus) vaccine sufficiently protects against the more serious immediate precursor to invasive cervical cancer (ICC), particularly when given to young adolescent girls before they become sexually active, according to this study. In addition the vaccine partially protects against four other cancer-causing HPV types not targeted by the formulations. "Provided that organized vaccination programs achieve high coverage in early adolescents before...

By: Alicia Rose DelGallo, Ivanhoe Health Correspondent (Ivanhoe Newswire) -- Parents of teenagers aged 13 to 17 years old are not vaccinating their teens against major diseases, even though they understand the importance, a new study shows. A recent online survey, done by the American Osteopathic Association (AOA) showed significant differences between the perceived importance and whether parents’ teens were fully vaccinated. The survey, released at the AOA’s OMED 2011 conference...

(Ivanhoe Newswire) -- A new Do-It-Yourself screen for cervical cancer could help prevent the disease in thousands of women who, for a number of reasons, cannot have a smear test. The test, which detects the virus responsible for cervical cancer, was widely accepted by women in the trial and was more effective than the traditional smear test at picking up earliest signs of the disease. The study was led by Professor Attila Lorincz, Queen Mary, University of London and was tested on over...

Nerissa Oden's free e-book is for anyone who has gotten a bad pap result or has been told that they have cervical dysplasia or anal dysplasia. It’s for anyone who is concerned about the harmful effects from human papillomavirus (HPV). Most importantly, this e-book gives women and men hope to heal their bodies naturally and overcome the virus. Wimberley, TX (PRWEB) November 02, 2011 Vaginal self-sampling for Human Papillomavirus (HPV) at home could unveil many cases of cervical...

A study published today in The Lancet shows how a do-it-yourself screen for cervical cancer could help prevent the disease in thousands of women who, for a number of reasons, cannot have a smear test. The test, which detects the virus responsible for cervical cancer, was widely accepted by women in the trial and was more effective than the traditional smear test at picking up the earliest signs of the disease. The DIY test has the potential to help thousands of women around the world...

HILDEN, Germany and GAITHERSBURG, Maryland, November 2, 2011 /PRNewswire/ -- - Vaginal Self-collection for Hybrid Capture(R)-based HPV Testing Increases Screening Coverage and is More Sensitive than Pap Smear Shows a Mexican Study Published Today Online in the Lancet Promising findings published today online in the Lancet[1] from a community-based, randomized equivalence trial undertaken by public health authorities in Mexico to investigate DNA home testing for human...

American Osteopathic Association Survey Shows Only About 35% of Teenagers Received HPV Vaccine ORLANDO, Fla., Nov. 1, 2011 /PRNewswire-USNewswire/ -- Concerns about vaccinations are not limited to parents of young children. In fact, while the majority of parents see the importance of making sure their children ages 13 to 17 are current on national recommendations for vaccinations, there is a significant difference between the perceived importance and whether their children were fully...

SAN DIEGO, Oct. 31, 2011 /PRNewswire/ -- Gen-Probe Incorporated (NASDAQ: GPRO) announced today that the US Food and Drug Administration (FDA) has approved its APTIMA HPV assay, an amplified nucleic acid test that detects high-risk strains of human papillomavirus (HPV) that are associated with cervical cancer and precancerous lesions. The test has been approved to run on Gen-Probe's fully automated, high-throughput TIGRIS instrument system. "We believe our APTIMA HPV assay will offer...

BLUE BELL, Pa., Oct. 31, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), which is advancing synthetic vaccines to fight cancers and infectious diseases, announced today that VGX-3100, its investigational SynCon® vaccine for treating cervical dysplasia and cancer caused by human papillomavirus, was highlighted by Fierce Vaccines as one of 10 Promising Therapeutic Vaccines (see VGX-3100 - Cervical cancer). Inovio is currently enrolling patients with CIN 2/3 or CIN 3...

TUCSON, Ariz., Oct. 27, 2011 /PRNewswire-USNewswire/ -- The CDC has added still another vaccine to the recommended list: three doses of human papillomavirus (HPV) vaccine (Gardasil) for boys age 11-12. HPV causes genital warts, and four of about 100 strains have been linked to cancer, especially cervical cancer in women. Controversy over Governor Rick Perry's effort to mandate the vaccine for sixth-grade girls spilled into the Presidential campaign when he was criticized by Michele...